A new report shows while cancer death rates among Black people are declining, they remain higher than other racial and ethnic ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

Over 90% adherence to relugolix in patients with Medicare with prostate cancer for 24 months supports its use as androgen ...

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

Many Medicare patients with advanced cancer receive potentially aggressive treatment at the expense of supportive care, according to a study that analyzed Medicare records.

Black individuals had a 2-fold risk of cancer death related to prostate, myeloma, and stomach cancers compared with White ...

OPTYX study shows many patients with advanced prostate cancer preferred oral relugolix over injectables for androgen deprivation therapy.

For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR ...

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...